|
Healthcare professional reported injecting a patient in the subcutaneous plane of the mental crease with 0.15 cc juvéderm® ultra plus xc.The injector went down to the bone and aspirated first to check for vasculature.The patient had ¿initial soreness.¿ approximately 24-48h later, the patient reported ¿pain¿ in the gums and general jaw area and visualized ¿small, pimple-like lesion with pus coming out¿ of the injection site.The patient was treated with doxycycline for 10 days, asa 325, and a warm compress the next day.The patient has a history of back issues and hypothyroidism, a history or previous juvéderm® ultra and juvéderm® ultra plus and takes synthroid concomitantly.The event is ongoing, but the swelling has come down.
|
|
Further information regarding event, product, or patient details has been requested.No additional information is available at this time.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.A review of the device history record has been completed.No deviations or non-conformances noted.This is a known potential adverse event addressed in the product labeling.
|